Edski et al.
Some good discussion here so far...yes it makes sense that the placebo effect can also go the other way, ie in a double blinded trial you may think you aren't getting the real drug and this would possibly balance out to some effect.
Here were some other interesting points I came across regarding Placebo:
That second bullet point was interesting, placebo effect can work in some cases even if the patient is sceptical.
Agree with you that we may possibly need to make a distinction between pill format and subQ, specially at a Doc (and Medical association level).
IC still affects a few million patients which is a fairly high number.
Our eventual data and the great results (my views) from P3 will do a lot of the talking too.
Good to get your thoughts.
Ref
https://www.betterhealth.vic.gov.au/health/conditionsandtreatments/placebo-effect
https://www.niddk.nih.gov/health-information/urologic-diseases/interstitial-cystitis-painful-bladder-syndrome/definition-facts#:~:text=IC%20is%20common.,men%20in%20the%20United%20States.
- Forums
- ASX - By Stock
- research reports and media
Edski et al.Some good discussion here so far...yes it makes...
-
- There are more pages in this discussion • 1,585 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
|
|||||
Last
23.0¢ |
Change
-0.005(2.13%) |
Mkt cap ! $80.45M |
Open | High | Low | Value | Volume |
23.5¢ | 24.0¢ | 23.0¢ | $63.43K | 270.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 213534 | 23.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
23.5¢ | 76890 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 201534 | 0.230 |
10 | 115252 | 0.225 |
11 | 96477 | 0.220 |
3 | 47958 | 0.215 |
6 | 85461 | 0.210 |
Price($) | Vol. | No. |
---|---|---|
0.235 | 76890 | 2 |
0.240 | 703 | 1 |
0.245 | 59096 | 2 |
0.250 | 63573 | 3 |
0.255 | 29564 | 3 |
Last trade - 16.10pm 05/09/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |